Literature DB >> 24173536

Atypical femoral fractures: retrospective radiological study of 319 femoral fractures and presentation of clinical cases.

V Bottai1, S Giannotti, G Dell'osso, G De Paola, A Menconi, F Falossi, G Raffaetà, G Guido.   

Abstract

SUMMARY: There is still no clarity on the etiology and epidemiology of atypical femoral fractures. The purpose is to show, after a radiological review, that the incidence of atypical fractures is higher than that reported in the literature when compared to "typical" fractures that occurred in the same anatomical site.
INTRODUCTION: At present, it is difficult to define the true incidence of atypical fractures associated with bisphosphonate. Our purpose is to show that the incidence of atypical fractures is higher than that reported in the literature when compared to "typical" fractures that occurred in the same anatomical site.
METHODS: The authors analyzed 319 femoral fracture Rxs of patients over 60 who have had access to the PS of Clinical Orthopaedics and Traumatology II of the University of Pisa from January 2011 to February 2013. The atypical fractures have been investigated from clinical point of view, biohumoral exams, densitometry and contralateral femur X-rays, and in one case using SPECT-Tc.
RESULTS: The total number of femoral fractures was 319. The medial femur fractures were 60 (46 females and 14 males), and the lateral ones were 316 (237 females and 79 males). Subtrochanteric and diaphyseal fractures were 40 (29 females and 11 males). Among these cases, two atypical fracture cases were related to female patients, one was 79 years old and the other was 77.
CONCLUSIONS: The most recent literature reports that the incidence of atypical fractures is 0.6 %. However, taking into consideration only the fracture locations suitable for the identification of atypical fractures, the percentage rises to 5 %. To date, there is still no clarity on the exact etiology of fractures even if it seems to be related to a bone mineral component alteration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24173536     DOI: 10.1007/s00198-013-2546-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  16 in total

1.  Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide.

Authors:  N N C Carvalho; L A Voss; M O P Almeida; C L Salgado; F Bandeira
Journal:  J Clin Endocrinol Metab       Date:  2011-07-13       Impact factor: 5.958

2.  Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

Authors:  Brett A Lenart; Dean G Lorich; Joseph M Lane
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

Review 3.  Atypical femoral fractures: what do we know about them?: AAOS Exhibit Selection.

Authors:  Aasis Unnanuntana; Anas Saleh; Kofi A Mensah; John P Kleimeyer; Joseph M Lane
Journal:  J Bone Joint Surg Am       Date:  2013-01-16       Impact factor: 5.284

4.  Atrophic femoral nonunion successfully treated with teriparatide.

Authors:  S Giannotti; V Bottai; G Dell'Osso; G de Paola; E Pini; G Guido
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-12-09

5.  Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features.

Authors:  Andrea Giusti; Neveen A T Hamdy; Olaf M Dekkers; Sharita R Ramautar; Sander Dijkstra; Socrates E Papapoulos
Journal:  Bone       Date:  2010-12-31       Impact factor: 4.398

6.  Atypical femur fractures: a review of the evidence and its implication to clinical practice.

Authors:  Christian M Girgis; Markus J Seibel
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-12       Impact factor: 5.346

Review 7.  Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw.

Authors:  J Compston
Journal:  Osteoporos Int       Date:  2011-10-14       Impact factor: 4.507

8.  Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles.

Authors:  T Mashiba; C H Turner; T Hirano; M R Forwood; C C Johnston; D B Burr
Journal:  Bone       Date:  2001-05       Impact factor: 4.398

9.  Treatment of femoral fracture nonunion after long-term bisphosphonate use.

Authors:  Mary K Grady; J Tracy Watson; Lisa K Cannada
Journal:  Orthopedics       Date:  2012-06       Impact factor: 1.390

10.  Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study.

Authors:  Bo Abrahamsen; Pia Eiken; Richard Eastell
Journal:  J Bone Miner Res       Date:  2009-06       Impact factor: 6.741

View more
  11 in total

1.  The incidence of and risk factors for developing atypical femoral fractures in Japan.

Authors:  Yoshitomo Saita; Muneaki Ishijima; Atsuhiko Mogami; Mitsuaki Kubota; Tomonori Baba; Takefumi Kaketa; Masashi Nagao; Yuko Sakamoto; Kensuke Sakai; Yasuhiro Homma; Rui Kato; Nana Nagura; Kei Miyagawa; Tomoki Wada; Lizu Liu; Joe Matsuoka; Osamu Obayashi; Katsuo Shitoto; Masahiko Nozawa; Hajime Kajihara; Hogaku Gen; Kazuo Kaneko
Journal:  J Bone Miner Metab       Date:  2014-05-23       Impact factor: 2.626

Review 2.  The hip prosthesis in lateral femur fracture: current concepts and surgical technique.

Authors:  Stefano Giannotti; Vanna Bottai; Giacomo Dell'Osso; Gaia De Paola; Giulia Bugelli; Giulio Guido
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

3.  Pathological pelvic fracture following long-term bisphosphonate use in a 63-year-old woman.

Authors:  H I Watson; G P Hopper; S Gupta; J L Roberts
Journal:  BMJ Case Rep       Date:  2014-10-13

4.  Reduced diaphyseal strength associated with high intracortical vascular porosity within long bones of children with osteogenesis imperfecta.

Authors:  Carolyne Albert; John Jameson; Peter Smith; Gerald Harris
Journal:  Bone       Date:  2014-06-11       Impact factor: 4.398

5.  Atypical femoral fractures in Italy: a retrospective analysis in a large urban emergency department during a 7-year period (2007-2013).

Authors:  Mario Pedrazzoni; Andrea Giusti; Giuseppe Girasole; Barbara Abbate; Ignazio Verzicco; Gianfranco Cervellin
Journal:  J Bone Miner Metab       Date:  2016-11-09       Impact factor: 2.626

6.  Atypical periprosthetic acetabular fracture in long-term alendronate therapy.

Authors:  Giuseppe Marongiu; Antonio Capone
Journal:  Clin Cases Miner Bone Metab       Date:  2017-02-10

7.  Total hip replacement in osteoarthritis: the role of bone metabolism and its complications.

Authors:  Vanna Bottai; Giacomo Dell'Osso; Fabio Celli; Giulia Bugelli; Niki Cazzella; Elena Cei; Giulio Guido; Stefano Giannotti
Journal:  Clin Cases Miner Bone Metab       Date:  2015-12-29

8.  Combined Surgical and Medical Treatment for Vancouver B1 and C Periprosthetic Femoral Fractures: A Proposal of a Therapeutic Algorithm While Retaining the Original Stable Stem.

Authors:  Nicola Mondanelli; Elisa Troiano; Andrea Facchini; Martina Cesari; Giovanni Battista Colasanti; Vanna Bottai; Francesco Muratori; Carla Caffarelli; Stefano Gonnelli; Stefano Giannotti
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-12-21

9.  Histological study of atraumatic periprosthetic fractures: does atypical periprosthetic fracture exist?

Authors:  Vanna Bottai; Gaia De Paola; Fabio Celli; Ilaria Lazzerini; Valerio Ortenzi; Antonio Giuseppe Naccarato; Giulio Guido; Rodolfo Capanna; Stefano Giannotti
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

Review 10.  Management of atypical femoral fracture: a scoping review and comprehensive algorithm.

Authors:  Giuseppe Toro; Cristina Ojeda-Thies; Giampiero Calabrò; Gabriella Toro; Antimo Moretti; Guillermo Martínez-Díaz Guerra; Pedro Caba-Doussoux; Giovanni Iolascon
Journal:  BMC Musculoskelet Disord       Date:  2016-05-23       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.